Vaginal rehabilitative device

• US 9,320,893 B2
• Filed: 04/15/2013
• Issued: 04/26/2016
• Est. Priority Date: 05/06/2011
• Status: Active Grant

• Current Assignee: Blue Medical Innovation Ltd.
• Original Assignee: Blue Medical Innovation Ltd.
• Inventors: Hagege, Edward
• Primary Examiner(s): GETZOW, SCOTT M
• Application Number:
  US13/862,555
• Publication Number:
  US 20130274823A1
• Time in Patent Office: 1,107 Days
• Field of Search: 607 39- 41, 607/138
• US Class Current: 1/1
• CPC Class Codes: A61N 1/0524 Vaginal electrodes
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/37241 providing test stimulations

Abstract

A vaginal rehabilitative device comprising: a vaginal electrical stimulation applicator; and a control module connectable by a wire to said applicator and comprising a user interface for controlling electrical stimuli by said applicator and a display module configured to display data received from said applicator.

Claims

1. A vaginal rehabilitative device comprising:

a liquid-sealed vaginal electrical stimulation applicator, comprising;

a) two stimulation electrodes configured to apply a voltage for executing an electrical stimuli, and

b) a detection electrode that is configured to detect insertion of the applicator into a bodily cavity; and

a control module connectable by a wire to said applicator and comprising (a) a user interface for controlling the electrical stimuli applied by said applicator and (b) a display module configured to display data received from said applicator,

wherein, responsive to a signal from the detection electrode indicating that the applicator is inserted within the bodily cavity, the control module is configured to allow selection of a treatment program in accordance with a physiological sensitivity threshold determined via a sensitivity test, and

wherein, responsive to a signal from the detection electrode indicating that the applicator is not inserted within the bodily cavity, the control module is configured to prevent the application of the electrical stimuli.

2. The device according to claim 1, wherein said applicator is shaped as an oblong cylinder.

3. The device according to claim 1, wherein said applicator further comprises a sensor configured (a) to detect muscular contraction in reaction to the electrical stimuli and (b) to adapt the electrical stimuli, in real time, corresponding to the muscular contraction.

4. The device according to claim 3, wherein said sensor is a pressure sensor configured to sense muscle contraction.

5. The device according to claim 1, wherein said applicator further comprises a sensor configured to detect a body reaction to the electrical stimuli and to provide feedback of treatment effectiveness corresponding to the body reaction.

6. The device according to claim 5, wherein said sensor is a pressure sensor configured to sense muscle contraction.

7. The device according to claim 1, wherein said control module further comprises at least one energy storage unit.

8. The device according to claim 1, wherein said control module further comprises at least one microprocessor.

9. The device according to claim 1, wherein said control module further comprises a memory configured for storing treatment history data.

10. The device according to claim 1, wherein said applicator and said control module are configured to communicate via a bidirectional wired communication protocol.

11. The device according to claim 1, wherein said control module is further configured to communicate with a computer via a wired communication protocol.

12. The device according to claim 1, wherein said control module is further configured to communicate with a computer via a wireless communication protocol.

13. The device according to claim 1, wherein each of the at least two stimulation electrodes is annular.

14. The device according to claim 13, wherein the at least two stimulation electrodes are disposed within the distal four centimeters of the applicator.

15. The device according to claim 1, wherein:

responsive to a signal from the detection electrode indicating that the applicator is inserted within the bodily cavity, said control module is configured to perform the sensitivity test by;

a) gradually increasing the intensity of the electrical stimuli;

b) responsive to a signal received from said user interface indicating a moment at which the electrical stimuli begins to be felt by a user, defining the physiological sensitivity threshold in accordance with the indicated moment; and

c) storing data corresponding to the physiological sensitivity threshold, thereby allowing the selection of the treatment program in accordance with the defined physiological sensitivity threshold.